FdaApplication
NDA 213407
Identifiers
- fda_app_no: NDA213407
Properties
| Property | Value |
|---|---|
| applicant_name | NEXUS PHARMACEUTICALS LLC |
| application_type | NDA |
| approval_date | 2020-04-17 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| EMERPHED | EPHEDRINE SULFATE | 50MG/10ML (5MG/ML) | SOLUTION;INTRAVENOUS |
| EMERPHED | EPHEDRINE SULFATE | 25MG/5ML (5MG/ML) | SOLUTION;INTRAVENOUS |
2 products